Skip to main navigation Skip to search Skip to main content

Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry

  • Bahira Shahim
  • , Angiza Shahim
  • , Marianna Adamo
  • , Ovidiu Chioncel
  • , Lina Benson
  • , Maria G. Crespo-Leiro
  • , Stefan D. Anker
  • , Andrew J.S. Coats
  • , Gerasimos Filippatos
  • , Mitja Lainscak
  • , Theresa McDonagh
  • , Alexandre Mebazaa
  • , Massimo F. Piepoli
  • , Giuseppe M.C. Rosano
  • , Frank Ruschitzka
  • , Gianluigi Savarese
  • , Petar Seferovic
  • , Maurizio Volterrani
  • , Marisa Crespo Leiro
  • , Javier Segovia Cubero
  • Offer Amir, Benjamin Palic, Aldo P. Maggioni, Marco Metra, Lars H. Lund
  • Unit of Cardiology
  • Karolinska Institutet
  • Cardiology
  • University of Brescia
  • Emergency Institute for Cardiovascular Diseases ‘Prof. C.C. Iliescu’
  • Carol Davila University of Medicine and Pharmacy
  • Centro de Investigación Biomédica en Red
  • Charité – Universitätsmedizin Berlin
  • Scientific Director
  • Heart Research Institute
  • Heart Failure Unit
  • Attikon University Hospital
  • University of Ljubljana
  • King's College Hospital
  • Department of Anesthesia-Burn-Critical Care
  • Assistance publique – Hôpitaux de Paris
  • IRCCS Policlinico San Donato
  • IRCCS San Raffaele Pisana - Roma
  • Clinic of Cardiology
  • University of Zurich
  • University of Belgrade
  • University of A Coruna
  • Hospital Universitario Puerta de Hierro Majadahonda
  • Carmel Medical Center
  • Univ Clin Hosp Mostar
  • Associazione Nazionale Medici Cardiologi Ospedalieri

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Aims: To assess the prevalence, clinical characteristics, and outcomes of patients with heart failure (HF) with or without moderate to severe aortic valve disease (AVD) (aortic stenosis [AS], aortic regurgitation [AR], mixed AVD [MAVD]). Methods and results: Data from the prospective ESC HFA EORP HF Long-Term Registry including both chronic and acute HF were analysed. Of 15 216 patients with HF (62.5% with reduced ejection fraction, HFrEF; 14.0% with mildly reduced ejection fraction, HFmrEF; 23.5% with preserved ejection fraction, HFpEF), 706 patients (4.6%) had AR, 648 (4.3%) AS and 234 (1.5%) MAVD. The prevalence of AS, AR and MAVD was 6%, 8%, and 3% in HFpEF, 6%, 3%, and 2% in HFmrEF and 4%, 3%, and 1% in HFrEF. The strongest associations were observed for age and HFpEF with AS, and for left ventricular end-diastolic diameter with AR. AS (adjusted hazard ratio [HR] 1.43, 95% confidence interval [CI] 1.23–1.67), and MAVD (adjusted HR 1.37, 95% CI 1.07–1.74) but not AR (adjusted HR 1.13, 95% CI 0.96–1.33) were independently associated with the 12-month composite outcome of cardiovascular death and HF hospitalization. The associations between AS and the composite outcome were observed regardless of ejection fraction category. Conclusions: In the ESC HFA EORP HF Long-Term Registry, one in 10 patients with HF had AVD, with AS and MAVD being especially common in HFpEF and AR being similarly distributed across all ejection fraction categories. AS and MAVD, but not AR, were independently associated with increased risk of in-hospital mortality and 12-month composite outcome, regardless of ejection fraction category.

Original languageEnglish
Pages (from-to)1049-1060
Number of pages12
JournalEuropean Journal of Heart Failure
Volume25
Issue number7
Early online date21 May 2023
DOIs
StatePublished - Jul 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Keywords

  • Aortic regurgitation
  • Aortic stenosis
  • Aortic valve disease
  • Ejection fraction
  • Heart failure
  • Mixed aortic valve disease

Fingerprint

Dive into the research topics of 'Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry'. Together they form a unique fingerprint.

Cite this